dc.date.accessioned2022-01-18T19:34:37Z
dc.date.available2022-01-18T19:34:37Z
dc.date.created2022-01-18T19:34:37Z
dc.date.issued2011
dc.identifierhttps://hdl.handle.net/20.500.12866/11059
dc.identifierhttps://doi.org/10.1371/journal.pmed.1001064
dc.description.abstractCarlton Evans considers whether the new tuberculosis diagnostic test, GeneXpert, is the solution for TB control that it's said to be.
dc.languageeng
dc.publisherPublic Library of Science
dc.relationPLoS Medicine
dc.relation1549-1676
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectHumans
dc.subjectSensitivity and Specificity
dc.subjectPoint-of-Care Systems
dc.subjectAntibiotics, Antitubercular pharmacology
dc.subjectDiagnostic Tests, Routine instrumentation methods
dc.subjectDNA, Bacterial analysis genetics
dc.subjectDrug Resistance, Bacterial drug effects
dc.subjectMolecular Diagnostic Techniques methods
dc.subjectMycobacterium tuberculosis classification drug effects genetics isolation, purification
dc.subjectNucleic Acid Amplification Techniques methods
dc.subjectRifampin pharmacology
dc.subjectTuberculosis, Multidrug-Resistant complications diagnosis microbiology
dc.subjectTuberculosis, Pulmonary complications diagnosis microbiology
dc.subjectTuberculosis diagnosis microbiology
dc.titleGeneXpert--a game-changer for tuberculosis control?
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución